Several studies documented the lack of efficacy of SMO inhibitors, alone or in combination with chemotherapy, in a range of tumours [54–58], even though in some cases, a reduction in GLI1 expression levels was observed in tumour tissues. This evidence concerns the gene GLI1 and neoplasm.